These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29898608)

  • 1. Shining a light on cell signaling in leukemia through proteomics: relevance for the clinic.
    Hoff FW; Hu CW; Qutub AA; de Bont ESJM; Horton TM; Kornblau SM
    Expert Rev Proteomics; 2018 Jul; 15(7):613-622. PubMed ID: 29898608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.
    Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U
    Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse phase protein arrays in acute leukemia: investigative and methodological challenges.
    Hoff FW; Horton TM; Kornblau SM
    Expert Rev Proteomics; 2021 Dec; 18(12):1087-1097. PubMed ID: 34965151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective.
    van Dijk AD; de Bont ESJM; Kornblau SM
    Expert Rev Proteomics; 2020 Jan; 17(1):1-10. PubMed ID: 31945303
    [No Abstract]   [Full Text] [Related]  

  • 5. Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer.
    Lu Y; Ling S; Hegde AM; Byers LA; Coombes K; Mills GB; Akbani R
    Semin Oncol; 2016 Aug; 43(4):476-83. PubMed ID: 27663479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling pathway profiling using reverse-phase protein array and its clinical applications.
    Masuda M; Yamada T
    Expert Rev Proteomics; 2017 Jul; 14(7):607-615. PubMed ID: 28621158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia.
    van Dijk AD; Hoff FW; Qiu YH; Chandra J; Jabbour E; de Bont ESJM; Horton TM; Kornblau SM
    Clin Epigenetics; 2021 Jan; 13(1):21. PubMed ID: 33509276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of sample handling on proteomics assessed by reverse phase protein arrays (RPPA): Functional proteomic profiling in leukemia.
    Horton TM; Hoff FW; van Dijk A; Jenkins GN; Morrison D; Bhatla T; Hogan L; Romanos-Sirakis E; Meyer J; Carroll WL; Qiu Y; Wang T; Mo Q; Kornblau SM
    J Proteomics; 2021 Feb; 233():104046. PubMed ID: 33212251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of reverse phase protein microarrays to study protein expression in leukemia: technical and methodological lessons learned.
    Kornblau SM; Coombes KR
    Methods Mol Biol; 2011; 785():141-55. PubMed ID: 21901598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility and Crossplatform Validation of Reverse-Phase Protein Array Data.
    Byron A
    Adv Exp Med Biol; 2019; 1188():181-201. PubMed ID: 31820389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling pathway profiling by reverse-phase protein array for personalized cancer medicine.
    Masuda M; Yamada T
    Biochim Biophys Acta; 2015 Jun; 1854(6):651-7. PubMed ID: 25448010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.
    Tibes R; Qiu Y; Lu Y; Hennessy B; Andreeff M; Mills GB; Kornblau SM
    Mol Cancer Ther; 2006 Oct; 5(10):2512-21. PubMed ID: 17041095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
    Clarke CN; Lee MS; Wei W; Manyam G; Jiang ZQ; Lu Y; Morris J; Broom B; Menter D; Vilar-Sanchez E; Raghav K; Eng C; Chang GJ; Simon I; Bernards R; Overman M; Mills GB; Maru D; Kopetz S
    Ann Surg Oncol; 2017 Dec; 24(13):4051-4058. PubMed ID: 28936799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoprotein DIGE profiles reflect blast differentiation, cytogenetic risk stratification, FLT3/NPM1 mutations and therapy response in acute myeloid leukaemia.
    Forthun RB; Aasebø E; Rasinger JD; Bedringaas SL; Berven F; Selheim F; Bruserud Ø; Gjertsen BT
    J Proteomics; 2018 Feb; 173():32-41. PubMed ID: 29175091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein biomarkers for subtyping breast cancer and implications for future research.
    Mueller C; Haymond A; Davis JB; Williams A; Espina V
    Expert Rev Proteomics; 2018 Feb; 15(2):131-152. PubMed ID: 29271260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane proteomics for leukemia classification and drug target identification.
    Kohnke PL; Mulligan SP; Christopherson RI
    Curr Opin Mol Ther; 2009 Dec; 11(6):603-10. PubMed ID: 20072937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
    Yocum AK; Busch CM; Felix CA; Blair IA
    J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New era of integrated cancer biomarker discovery using reverse-phase protein arrays.
    Nishizuka SS; Mills GB
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):35-45. PubMed ID: 26822993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass Spectrometry: A Powerful Method for Monitoring Various Type of Leukemia, Especially MALDI-TOF in Leukemia's Proteomics Studies Review.
    Fasih Ramandi N; Faranoush M; Ghassempour A; Aboul-Enein HY
    Crit Rev Anal Chem; 2022; 52(6):1259-1286. PubMed ID: 33499652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.